These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 34329659)
41. MRGPRX2 Activation by Rocuronium: Insights from Studies with Human Skin Mast Cells and Missense Variants. Chompunud Na Ayudhya C; Amponnawarat A; Roy S; Oskeritzian CA; Ali H Cells; 2021 Jan; 10(1):. PubMed ID: 33467419 [TBL] [Abstract][Full Text] [Related]
42. Imperatorin ameliorates mast cell-mediated allergic airway inflammation by inhibiting MRGPRX2 and CamKII/ERK signaling pathway. Wang N; Wang J; Zhang Y; Zeng Y; Hu S; Bai H; Hou Y; Wang C; He H; He L Biochem Pharmacol; 2021 Feb; 184():114401. PubMed ID: 33387483 [TBL] [Abstract][Full Text] [Related]
43. Substance P analogs devoid of key residues fail to activate human mast cells Raj S; Hlushak S; Arizmendi N; Kovalenko A; Kulka M Front Immunol; 2023; 14():1155740. PubMed ID: 37228611 [TBL] [Abstract][Full Text] [Related]
45. Measurement and Functional Analysis of the Mas-Related G Protein-Coupled Receptor MRGPRX2 on Human Mast Cells and Basophils. Elst J; Sabato V; Hagendorens MM; van Houdt M; Faber MA; Bridts CH; Ebo DG; Mertens C Methods Mol Biol; 2020; 2163():219-226. PubMed ID: 32766979 [TBL] [Abstract][Full Text] [Related]
46. Cisatracurium induces mast cell activation and pseudo-allergic reactions via MRGPRX2. Che D; Rui L; Cao J; Wang J; Zhang Y; Ding Y; Zhao T; Ma P; An H; Gao Z; Zhang T Int Immunopharmacol; 2018 Sep; 62():244-250. PubMed ID: 30032049 [TBL] [Abstract][Full Text] [Related]
47. Activation of Mast-Cell-Expressed Mas-Related G-Protein-Coupled Receptors Drives Non-histaminergic Itch. Meixiong J; Anderson M; Limjunyawong N; Sabbagh MF; Hu E; Mack MR; Oetjen LK; Wang F; Kim BS; Dong X Immunity; 2019 May; 50(5):1163-1171.e5. PubMed ID: 31027996 [TBL] [Abstract][Full Text] [Related]
48. Role of activator protein 1, nuclear factor-kappaB, and nuclear factor of activated T cells in IgE receptor-mediated cytokine expression in mature human mast cells. Lorentz A; Klopp I; Gebhardt T; Manns MP; Bischoff SC J Allergy Clin Immunol; 2003 May; 111(5):1062-8. PubMed ID: 12743571 [TBL] [Abstract][Full Text] [Related]
49. MRGPRX2 and Adverse Drug Reactions. McNeil BD Front Immunol; 2021; 12():676354. PubMed ID: 34421893 [TBL] [Abstract][Full Text] [Related]
50. Resveratrol Suppresses Cytokine Production Linked to FcεRI-MAPK Activation in IgE-Antigen Complex-Exposed Basophilic Mast Cells and Mice. Han SY; Choi YJ; Kang MK; Park JH; Kang YH Am J Chin Med; 2015; 43(8):1605-23. PubMed ID: 26621445 [TBL] [Abstract][Full Text] [Related]
51. Overexpression of FcεRI on Bone Marrow Mast Cells, but Not MRGPRX2, in Clonal Mast Cell Disorders With Wasp Venom Anaphylaxis. Elst J; De Puysseleyr LP; Ebo DG; Faber MA; Van Gasse AL; van der Poorten MM; Decuyper II; Bridts CH; Mertens C; Van Houdt M; Hagendorens MM; De Clerck LS; Verlinden A; Vermeulen K; Maes MB; Berneman ZN; Valent P; Sabato V Front Immunol; 2022; 13():835618. PubMed ID: 35281031 [TBL] [Abstract][Full Text] [Related]
52. Fisetin alleviates chronic urticaria by inhibiting mast cell activation via MRGPRX2. Zhang Y; Huang Y; Dang B; Hu S; Zhao C; Wang Y; Yuan Y; Liu R J Pharm Pharmacol; 2023 Oct; 75(10):1310-1321. PubMed ID: 37410860 [TBL] [Abstract][Full Text] [Related]
53. Degranulation of Mast Cells as a Target for Drug Development. Yang BG; Kim AR; Lee D; An SB; Shim YA; Jang MH Cells; 2023 May; 12(11):. PubMed ID: 37296626 [TBL] [Abstract][Full Text] [Related]
54. C3a-derived peptide binds to the type I FcepsilonR and inhibits proximal-coupling signal processes and cytokine secretion by mast cells. Péterfy H; Tóth G; Pecht I; Erdei A Int Immunol; 2008 Oct; 20(10):1239-45. PubMed ID: 18653698 [TBL] [Abstract][Full Text] [Related]
55. In silico design of novel probes for the atypical opioid receptor MRGPRX2. Lansu K; Karpiak J; Liu J; Huang XP; McCorvy JD; Kroeze WK; Che T; Nagase H; Carroll FI; Jin J; Shoichet BK; Roth BL Nat Chem Biol; 2017 May; 13(5):529-536. PubMed ID: 28288109 [TBL] [Abstract][Full Text] [Related]
56. Recent Knowledge and Insights on the Mechanisms of Immediate Hypersensitivity and Anaphylaxis: IgE/FcεRI- and Non-IgE/FcεRI-Dependent Anaphylaxis. Ebo DG; Beyens M; Heremans K; van der Poorten MM; Van Gasse AL; Mertens C; Houdt MV; Sabato V; Elst J Curr Pharm Des; 2023; 29(3):178-184. PubMed ID: 36284380 [TBL] [Abstract][Full Text] [Related]
57. SR-BI regulates the synergistic mast cell response by modulating the plasma membrane-associated cholesterol pool. Capellmann S; Kauffmann M; Arock M; Huber M Eur J Immunol; 2024 Aug; 54(8):e2350788. PubMed ID: 38708681 [TBL] [Abstract][Full Text] [Related]
58. Tetraspanin CD151 Is a Negative Regulator of FcεRI-Mediated Mast Cell Activation. Abdala-Valencia H; Bryce PJ; Schleimer RP; Wechsler JB; Loffredo LF; Cook-Mills JM; Hsu CL; Berdnikovs S J Immunol; 2015 Aug; 195(4):1377-87. PubMed ID: 26136426 [TBL] [Abstract][Full Text] [Related]
59. Mast cell degranulation and bradykinin-induced angioedema - searching for the missing link. Porebski G; Dziadowiec A; Rybka H; Kitel R; Kwitniewski M Front Immunol; 2024; 15():1399459. PubMed ID: 38812508 [TBL] [Abstract][Full Text] [Related]
60. FcεRI- and MRGPRX2-evoked acute degranulation responses are fully additive in human skin mast cells. Babina M; Wang Z; Li Z; Franke K; Guhl S; Artuc M; Zuberbier T Allergy; 2022 Jun; 77(6):1906-1909. PubMed ID: 35246987 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]